David Pellman
Director General, Health Canada (HC)·2 communications in the past year
Lobbied by
Cronos Group
2Seek amendments to the regulations and policies that govern the importation and exportation of medical cannabis. Elimination of the Health Canada annual 2.3% regulatory fee. Development of a framework to ensure consistent approach to the measurement and labeling of potency of cannabis products Amend the Excise Duty Framework for on Cannabis products to remove the $1.00 per gram duty with a 10% ad valorem rate. Amend the cannabis regulatory framework to permit cannabis licensed producers to more effectively communicate on the attributes of cannabis products with consumers. Amend the cannabis excise duty framework to eliminate the requirement that cannabis producers affix provincial / territory designated excise duty stamps to each individual package of cannabis, to be replaced by either a national excise duty stamp or a digital excise duty stamp.
Syqe Medical
2Discuss with the government critical barriers to providing innovative medical cannabis treatments for patients under the current implementation of the Cannabis Act.
Aurora Cannabis
1Governmental policy towards medical cannabis research, product quality standards, medical cost coverage, and displacement of harder and more addictive drugs Regulations affiliated with Bill C- 45 regarding the legalization of cannabis. Formerly known as Bill C-45: An Act Respecting Cannabis and to amend the Controlled Drugs and Substances Act, the Criminal Code and other Acts. Formerly known as Bill C-45: An Act Respecting Cannabis and to amend the Controlled Drugs and Substances Act, the Criminal Code and other Acts. Cannabis Act SC 2018 S16 Cannabis Act; phased implementation of the Act and its impact on medical patients; development of regulations for the industry and the resulting tax implications of these regulations. Canada's policy regarding the rules governing the legalization of marijuana
Organigram Global
1Advocacy for measures to reduce the federal regulatory burden and streamline administrative processes for the legal cannabis sector to improve efficiency and support economic competitiveness. Advocating for a stronger role for federal economic development ministries (e.g., Innovation, Science and Economic Development Canada or Agriculture and Agri-Food Canada) in shaping cannabis policy and programs. The goal is to ensure the sector is integrated into national agriculture and industrial strategies, enabling access to innovation funding, export development programs, and regional economic growth initiatives. This includes modernizing policies to support competitiveness, sustainability, and international trade opportunities for the cannabis industry. Advocacy related to fair competition in the legal cannabis sector, including efforts to support balanced market rules and to prevent undue concentration. Advocacy related to the need to develop a national cannabis export strategy Advocacy for enhanced consumer education and improved packaging and labeling regulations to support informed purchasing, promote safety, and strengthen the legal cannabis market. Advocacy for revising THC limits on cannabis edibles to align with consumer demand and global standards, reducing the appeal of unregulated products and strengthening the legal market. Advocacy for changes to Canada's cannabis excise tax framework to support industry competitiveness, reduce the illicit market, and enhance public policy objectives of legalization. Representations to government, Parliamentarians, and public servants regarding cannabis legalization, regulation, policy development, and program initiatives in Canada.